Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease

Lancet

Volumn 351, Issue 9111, 1998, Pages 1251-

  Deslys, Jean Philippe ^a,b,c   Jaegly, Alexandre ^a,b,c   D'Aignaux, Jerôme Huillard ^a,b,c   Mouthon, Franck ^a,b,c   De Villemeur, Thierry Billette ^a,b,c   Dormont, Dominique ^a,b,c  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PRION PROTEIN;

ARTICLE; CODON; CONTAMINATION; CREUTZFELDT JAKOB DISEASE; DISEASE PREDISPOSITION; GENOTYPE; HORMONAL THERAPY; HUMAN; PRIORITY JOURNAL;

EID: 0032565362     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79317-X     Document Type: Article

References (4)

1. 1 Billette de Villemeur T, Deslys J-P, Pradel A, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996; 47: 690-95.
2. 2 Deslys JP, Marcé D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994; 75: 23-27.
3. 3 Boussin F, Jaegly A, Deslys JP, Dormont D. A simple and rapid method for sequencing the entire coding region of the human Prion protein (PrP) gene. J Neurosci Meth 1994; 54: 103-07.
4. 4 Brown P, Cervenakova L, Goldfarb LG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994; 44: 291-93.